Clinical and Molecular Features of Late Onset Huntington Disease in a Peruvian Cohort

Journal of Huntington's Disease

Volumn 4, Issue 1, 2015, Pages 99-105

  Cornejo Olivas, Mario R ^a   Inca Martinez, Miguel A ^a   Espinoza Huertas, Keren ^a   Veliz Otani, Diego ^a   Velit Salazar, Mario R ^a,b   Marca, Victoria ^a   Ortega, Olimpio ^a   Cornejo Herrera, Ivan F ^a   Lindo Samanamud, Saul ^a   Mora Alferez, Pamela ^c   Mazzetti, Pilar ^a,d  

^a INSTITUTO NACIONAL DE CIENCIAS NEUROLÓGICAS   (Peru)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c INSTITUTO NACIONAL DE ENFERMEDADES NEOPLÁSICAS   (Peru)

^d UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

Author keywords

Age at onset; CAG repeat expansion; Huntington disease; late onset Huntington disease; Peru

Indexed keywords

ALLELE; ARTICLE; CAG REPEAT; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE TRANSMISSION; FAMILY HISTORY; GENE; GENOTYPE; HTT GENE; HUMAN; HUNTINGTON CHOREA; LATE ONSET HUNTINGTON DISEASE; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; MOTOR DYSFUNCTION; OBSERVATIONAL STUDY; ONSET AGE; PATERNAL TRANSMISSION; PATERNALISM; PEDIGREE; PERUVIAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTH AMERICA; SYSTEMATIC REVIEW; UNIFIED HUNTINGTON DISEASE RATING SCALE; AGED; COHORT ANALYSIS; FEMALE; GENETICS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PERU; TRINUCLEOTIDE REPEAT; VERY ELDERLY;

HTT PROTEIN, HUMAN; NERVE PROTEIN;

AGE OF ONSET; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PERU; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84930190683     PISSN: 18796397     EISSN: 18796400     Source Type: Journal    
DOI: 10.3233/JHD-140119     Document Type: Article

References (30)

1. Walker FO. Huntington's Disease. Semin Neurol. 2007;27:143-50.
2. Anovel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell. 1993;72:971-83.
3. Pringsheim T, Wiltshire K, Day L, Dykeman J, Steeves T, Jette N. The incidence and prevalence of Huntington's disease: A systematic review and meta-analysis. Mov Disord. 2012;27:1083-91.
4. Cuba JM, Castro C, Benzaquen M. Sobre la epidemiologia de la Corea de Huntington en el Peru. Rev Neuropsiquiatría. 1983;46:114-20.
5. Langbehn DR, Hayden M, Paulsen JS.CAG-repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches. Am JMed Genet B Neuropsychiatr Genet. 2010;153B:397-408.
6. Gómez-Tortosa E, del Barrio A, García Ruiz PJ, Pernaute RS, Benítez J, Barroso A, Jiménez FJ, García Yábenes J. Severity of cognitive impairment in juvenile and late-onset Huntington disease. Arch Neurol. 1998;55:835-43.
7. Alonso ME, Ochoa A, Boll MC, Sosa AL,Yescas P, López M, Macias R, Familiar I, Rasmussen A. Clinical and genetic characteristics of Mexican Huntington's disease patients. Mov Disord. 2009;24:2012-15.
8. Koutsis G, Karadima G, Kladi A, Panas M. Late-onset Huntington's disease: Diagnostic and prognostic considerations. Parkinsonism Relat Disord. 2014;20(7):726-30.
9. Lipe H, Bird T. Late onset Huntington disease: Clinical and genetic characteristics of 34 cases. J Neurol Sci. 2009;276:159-62.
10. Rosenblatt A, Kumar BV, Mo A, Welsh CS, Margolis RL, Ross CA. Age, CAG repeat length, and clinical progression in Huntington's disease. Mov Disord. 2012;27:272-76.
11. Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou LP, Davies P, MacDonald ME, Gusella JF, Harper PS, Shaw DJ. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet. 1993;4:393-97.
12. Warner JP, Barron LH, Brock DJ. A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol Cell Probes. 1993;7:235-39.
13. Kremer B, Squitieri F, Telenius H, Andrew SE, Theilmann J, Spence N, Goldberg YP, Hayden MR. Molecular analysis of late onset Huntington's disease. J Med Genet. 1993;30: 991-95.
14. Lovaton Espadin R, Timana Chavez C, Torres Alva G, Cornejo Olivas M, Marca Ysabel M, Ortega Davila O, Cosentino Esquerre C, Torres Ramirez L, Mazzetti Soler P. Huntington's disease in Peru: Spread of cases and Analysis of CAG triplet distribution in Peruvian population. 60th American Society of Human Genetics Annual Meetings, 2010, http:// www.ashg.org/2010meeting/abstracts/fulltext/f21354.htm.
15. James CM, Houlihan GD, Snell RG, Cheadle JP, Harper PS. Late-onset Huntington's disease: A clinical and molecular study. Age Ageing. 1994;23:445-48.
16. Hubers AA, van Duijn E, Roos RA, Craufurd D, Rickards H, Bernhard Landwehrmeyer G, van der Mast RC, Giltay EJ; REGISTRY investigators of the European Huntington's Disease Network. Suicidal ideation in a European Huntington's disease population. J Affect Disord. 2013;151:248-58.
17. Videnovic A, Bernard B, Fan W, Jaglin J, Leurgans S, Shannon KM. The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease. Mov Disord. 2010;25:401-04.
18. Gagnon G, Hansen KT, Woolmore-Goodwin S, Gutmanis I, Wells J, Borrie M, Fogarty J. Correcting the MoCA for education: Effect on sensitivity. Can J Neurol Sci. 2013;40:678-83.
19. Nitrini R, Caramelli P, Herrera Junior E, Porto CS, Charchat- Fichman H, Carthery MT, Takada LT, Lima EP. Performance of illiterate and literate nondemented elderly subjects in two tests of long-term memory. J Int Neuropsychol Soc. 2004;10:634-38.
20. Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, Marder K, Penchaszadeh G, Roberts SA, Gayán J, Brocklebank D, Cherny SS, Cardon LR, Gray J, Dlouhy SR, Wiktorski S, Hodes ME, Conneally PM, Penney JB, Gusella J, Cha JH, Irizarry M, Rosas D, Hersch S, Hollingsworth Z, MacDonald M, Young AB, Andresen JM, Housman DE, De Young MM, Bonilla E, Stillings T, Negrette A, Snodgrass SR, Martinez-Jaurrieta MD, Ramos-Arroyo MA, Bickham J, Ramos JS, Marshall F, Shoulson I, Rey GJ, Feigin A, Arnheim N, Acevedo-Cruz A, Acosta L, Alvir J, Fischbeck K, Thompson LM, Young A, Dure L, O'Brien CJ, Paulsen J, Brickman A, Krch D, Peery S, Hogarth P, Higgins DS Jr, Landwehrmeyer B; U.S.-Venezuela Collaborative Research Project. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci U S A. 2004;101:3498-503.
21. Dhaenens CM, Burnouf S, Simonin C, Van Brussel E, Duhamel A, Defebvre L, Duru C, Vuillaume I, Cazeneuve C, Charles P, Maison P, Debruxelles S, Verny C, Gervais H, Azulay JP, Tranchant C, Bachoud-Levi AC, Dürr A, Buée L, Krystkowiak P, Sablonnière B, Blum D; Huntington French Speaking Network. A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease. Neurobiol Dis. 2009;35:474-76.
22. Weydt P, Soyal SM, Gellera C, Didonato S, Weidinger C, Oberkofler H, Landwehrmeyer GB, PatschW. The gene coding for PGC-1alpha modifies age at onset in Huntington's Disease. Mol Neurodegener. 2009;4:3.
23. Falush D, Almqvist EW, Brinkmann RR, Iwasa Y, Hayden MR. Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases. Am J Hum Genet. 2001;68:373-85.
24. Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, Hayden MR, Warby SC, Morrison P, Nance M, Ross CA, Margolis RL, Squitieri F, Orobello S, Di Donato S, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJ, McCusker E, Novelletto A, Frontali M, Jones R, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente D, Harrison MB, Zanko A, Abramson RK, Marder K, Sequeiros J, Paulsen JS; PREDICT-HD study of the Huntington Study Group (HSG), Landwehrmeyer GB; REGISTRY study of the European Huntington's Disease Network, Myers RH; HD-MAPS Study Group, MacDonald ME, Gusella JF;COHORT study of the HSG. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology. 2012;78:690-95.
25. McMurray CT.Mechanisms of trinucleotide repeat instability during human development. Nat Rev Genet. 2010;11:786-99.
26. Aziz NA, van Belzen MJ, Coops ID, Belfroid RD, Roos RA. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease. Eur J Med Genet. 2011;54:e413-18.
27. Myers RH, Sax DS, Schoenfeld M, Bird ED, Wolf PA, Vonsattel JP,White RF, Martin JB. Late onset of Huntington's disease. J Neurol Neurosurg Psychiatry. 1985;48:530-34.
28. Morrison PJ, Johnston WP, Nevin NC. The epidemiology of Huntington's disease in Northern Ireland. J Med Genet. 1995;32:524-30.
29. Adams P, Falek A, Arnold J. Huntington disease in Georgia: Age at onset. Am J Hum Genet. 1988;43:695-704.
30. Almqvist E, Elterman D, MacLeod P, Hayden M. High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia. Clin Genet. 2001;60:198-205.